Nivolumab in Combination With Metronomic Chemotherapy in Paediatrics Refractory / Relapsing Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT03585465

Recruitment Status : Active, not recruiting

First Posted : July 13, 2018

Last Update Posted : May 6, 2024

View this study on the modernized ClinicalTrials.gov

Sponsor:

Collaborators:

Anticancer Fund, Belgium

Bristol-Myers Squibb

CTD-CNO

ECS-Progastrin SA

Information provided by (Responsible Party):

Centre Oscar Lambret

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Active, not recruiting
Estimated Primary Completion Date :	May 2025
Estimated Study Completion Date :	January 2028

To Top